| 1 |
34293069 | Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection. | 2021 Jul |
2 |
| 2 |
29414786 | The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis. | 2018 Mar 16 |
1 |
| 3 |
27065061 | ApoE: In Vitro Studies of a Small Molecule Effector. | 2016 May 10 |
1 |
| 4 |
27535051 | Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection. | 2016 Nov 1 |
1 |
| 5 |
25495659 | Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. | 2015 Jul |
1 |
| 6 |
23844141 | Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors. | 2013 |
1 |
| 7 |
22330584 | Comment on: heparin protects against septic mortality via apoE-antagonism. | 2012 Oct |
1 |
| 8 |
22370276 | Capillary electrochromatography and quartz crystal microbalance, valuable techniques in the study of heparin-lipoprotein interactions. | 2012 May 1 |
1 |
| 9 |
22532692 | Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. | 2012 Jul |
2 |
| 10 |
20679343 | Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. | 2010 Oct 22 |
2 |
| 11 |
20062740 | Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report. | 2009 Dec 2 |
2 |
| 12 |
17531997 | Structure-function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells. | 2008 Jan |
1 |
| 13 |
17441362 | [Purification of human VLDL apolipoproteins by middle pressure liquid chromatography]. | 2007 Mar |
1 |
| 14 |
17580963 | Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E. | 2007 Jul 17 |
1 |
| 15 |
16945147 | Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway. | 2006 Aug 31 |
1 |
| 16 |
15583000 | Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. | 2005 Feb 18 |
9 |
| 17 |
15228221 | Effect of L-ascorbic acid on the oxidative modification of apolipoprotein E in human very-low-density lipoprotein. | 2004 Feb |
1 |
| 18 |
12588864 | Characterization of the heparin binding sites in human apolipoprotein E. | 2003 Apr 25 |
8 |
| 19 |
12684504 | Structure-guided protein engineering modulates helix bundle exchangeable apolipoprotein properties. | 2003 Jun 13 |
2 |
| 20 |
12729008 | Effect of alpha-tocopherol on the oxidative modification of apolipoprotein E in human very-low-density lipoprotein. | 2003 Feb |
1 |
| 21 |
12810880 | Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion. | 2003 Jul |
1 |
| 22 |
14623192 | Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain. | 2003 Nov 28 |
1 |
| 23 |
12069613 | Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides. | 2002 Jun 25 |
3 |
| 24 |
12069854 | Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. | 2002 Jun 13 |
1 |
| 25 |
11181800 | Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy. | 2001 Mar |
5 |
| 26 |
11258893 | Interaction of the N-terminal domain of apolipoprotein E4 with heparin. | 2001 Mar 6 |
3 |
| 27 |
11350966 | Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation. | 2001 Jul 6 |
1 |
| 28 |
11500500 | New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. | 2001 Oct 19 |
2 |
| 29 |
11518760 | Dynamic and stable pools of apoE differ functionally at the HepG2 cell surface. | 2001 Sep |
1 |
| 30 |
12940068 | [Relationship between proteoglycans and apoE on the HepG2 cell surface]. | 2001 Aug |
1 |
| 31 |
10686395 | Heparin specifically inhibits binding of apolipoprotein E to amyloid beta-peptide. | 2000 Feb 18 |
4 |
| 32 |
10765057 | Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease. | 2000 |
2 |
| 33 |
10891598 | Binding specificity of monoclonal antibody AD2: influence of the phosphorylation state of tau. | 2000 May 31 |
1 |
| 34 |
10064733 | Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. | 1999 Mar |
1 |
| 35 |
10375392 | Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans. | 1999 Jul 1 |
2 |
| 36 |
10452964 | Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site. | 1999 Aug 30 |
6 |
| 37 |
9548597 | Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia. | 1998 Mar |
4 |
| 38 |
9162742 | Investigation of plasma membrane-associated apolipoprotein E in primary macrophages. | 1997 Feb |
2 |
| 39 |
9192073 | Bacterial overexpression, isotope enrichment, and NMR analysis of the N-terminal domain of human apolipoprotein E. | 1997 |
1 |
| 40 |
9221767 | Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. | 1997 Aug 1 |
1 |
| 41 |
9323595 | Isolation of subpopulations of high density lipoproteins: three particle species containing apoE and two species devoid of apoE that have affinity for heparin. | 1997 Sep |
1 |
| 42 |
12215771 | The Properties of Serum GPI-PLD. | 1997 |
1 |
| 43 |
8664327 | Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis. | 1996 Jun 11 |
1 |
| 44 |
8702993 | Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center. | 1996 Sep 6 |
2 |
| 45 |
8864947 | Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts. | 1996 Aug |
2 |
| 46 |
7635945 | Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu). | 1995 Aug |
1 |
| 47 |
7706948 | Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins. | 1995 Jan |
1 |
| 48 |
7775863 | Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia. | 1995 Mar |
6 |
| 49 |
7822240 | Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. | 1994 Aug |
1 |
| 50 |
8300609 | Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. | 1994 Jan 28 |
1 |